Moderna COVID Vaccine Developments

News

Moderna, COVID-19

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula,

Reuters on MSN · 3d

Moderna pulls application for COVID-flu combination shot

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza shot,

Insider Monkey on MSN · 1d

Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review

Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S. Food and Drug Administration (FDA) for review of its updated COVID-19 vaccine. The revised version of the vaccine,

2don MSN

Changes are happening around COVID-19 vaccines: Here's what to know

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

Devdiscourse16h

Health Headlines: Vaccines, Pharmaceuticals, and Public Health Challenges

Recent health news showcases key developments across various sectors. Jiangsu Hengrui and Mirxes have strong trading debuts, ...

STAT3d

How do we know mRNA vaccines are safe and effective? An explainer

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

1don MSN

What we know about the safety, efficacy of mRNA vaccines amid recent scrutiny

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

Live Science on MSN5d

2-in-1 COVID-flu vaccine looks promising, but approval could be delayed

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

STAT2d

FDA advisory panel split on whether agency should require updates of Covid-19 vaccine

Some members of the Vaccines and Related Biologics Products Advisory Committee worried that a strain change would require new ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results